Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus

• Główni autorzy: Anneleen Robberechts (Autor), Kaat Stas (Autor), Margot Puttemans (Autor), Laura Poppe (Autor), Stephane Steurbaut (Autor), Guido R. Y. De Meyer (Autor), Hans De Loof (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

BackgroundA type 3 medication review (MR3) is a patient-centred medication service primarily provided by pharmacists and is presently employed routinely in several countries. In this process, pharmacists interview patients and collaborate with the treating physician to optimize the patient's ph...